PanGen Biotech Inc (222110) — Long-term Investment Intensity

Latest as of December 2019: 0.0%

PanGen Biotech Inc (222110) has a Long-term Investment Intensity of 0.0% as of December 2019. Long-term investments of ₩60.00 represent 0.0% of total assets of ₩39.08 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check PanGen Biotech Inc (222110) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.0%
LT Investments / Total Assets

Long-term Investments

₩60.00
KRW

Total Assets

₩39.08 Billion
KRW

Country

Korea
KQ

PanGen Biotech Inc Long-term Investment Intensity (2014–2019)

This chart shows how PanGen Biotech Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 0.0%, reflecting long-term investments of ₩60.00 against total assets of ₩39.08 Billion KRW. Explore PanGen Biotech Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for PanGen Biotech Inc (2014–2019)

The table below presents the year-by-year Long-term Investment Intensity for PanGen Biotech Inc from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 222110 company net worth.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 0.0% ₩60.00 ₩39.08 Billion ▼ 0.0 pp
2018 0.0% ₩300.00 ₩45.61 Billion ▼ 0.0 pp
2017 0.0% ₩300.00 ₩35.59 Billion ▲ +0.0 pp
2016 0.0% ₩200.00 ₩37.40 Billion ▼ 0.0 pp
2015 0.0% ₩200.00 ₩15.90 Billion ▼ 0.0 pp
2014 0.0% ₩400.00 ₩16.87 Billion
pp = percentage points